Solid Biosciences Inc.

Solid Biosciences Inc.verified

SLDB

Price:

$7.14

Market Cap:

$556.28M

Solid Biosciences Inc. is an American biotechnology firm dedicated to creating therapeutic solutions for Duchenne Muscular Dystrophy (DMD). Its most advanced experimental drug, SGT-001, is a gene transfer treatment currently in Phase I/II clinical trials, designed to encourage the production of functional dystrophin protein in patients' muscles. The company is also progressing with SGT-003, which represents a next-generation gene transfer therapy intended for DMD. Beyond specific drug candidates, Solid Biosciences is actively developing innovative platform technologies, such as "dual gene expression," a technique that allows for multiple therapeutic genes to be bundled into a single viral ve...[Read more]

Industry

Biotechnology

IPO Date

2018-01-26

Stock Exchange

NASDAQ

Ticker

SLDB

The Enterprise Value as of June 2026 (TTM) for Solid Biosciences Inc. (SLDB) is 279.21M

According to Solid Biosciences Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 279.21M. This represents a change of -41.02% compared to the average of 473.40M of the last 4 quarters.

Solid Biosciences Inc. (SLDB) Historical Enterprise Value (quarterly & annually)

How has SLDB Enterprise Value performed in the past?

The mean historical Enterprise Value of Solid Biosciences Inc. over the last ten years is 289.01M. The current 279.21M Enterprise Value has changed 9.56% with respect to the historical average. Over the past ten years (40 quarters), SLDB's Enterprise Value was at its highest in in the September 2018 quarter at 1.47B. The Enterprise Value was at its lowest in in the December 2022 quarter at -83676498.76.

Quarterly (TTM)
Annual

Average

289.01M

Median

177.18M

Minimum

-81041961.18

Maximum

806.30M

Solid Biosciences Inc. (SLDB) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Solid Biosciences Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 324.20%

Maximum Annual Enterprise Value = 806.30M

Minimum Annual Increase = -216.15%

Minimum Annual Enterprise Value = -81041961.18

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2025454.79M324.20%
2024107.21M44.22%
202374.34M-191.73%
2022-81041961.18-216.15%
202169.78M-71.41%
2020244.04M121.21%
2019110.32M-86.32%
2018806.30M19.09%
2017677.08M58.45%
2016427.30M5.15%

Solid Biosciences Inc. (SLDB) Average Enterprise Value

How has SLDB Enterprise Value performed in the past?

The current Enterprise Value of Solid Biosciences Inc. (SLDB) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

212.11M

5-year avg

125.01M

10-year avg

289.01M

Solid Biosciences Inc. (SLDB) Enterprise Value vs. Peers

How is SLDB’s Enterprise Value compared to its peers?

Solid Biosciences Inc.’s Enterprise Value is less than Autolus Therapeutics plc (364.21M), greater than Quantum-Si incorporated (154.79M), greater than Rocket Pharmaceuticals, Inc. (275.44M), less than LB Pharmaceuticals Inc Common Stock (497.78M), less than Aura Biosciences, Inc. (343.72M), greater than Benitec Biopharma Inc. (109.56M), less than Annexon, Inc. (413.52M), greater than Neumora Therapeutics, Inc. Common Stock (183.14M), less than Design Therapeutics, Inc. (675.12M), less than RAPT Therapeutics, Inc. (923.92M),

Build a custom stock screener for Solid Biosciences Inc. (SLDB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Solid Biosciences Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Solid Biosciences Inc. (SLDB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Solid Biosciences Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Solid Biosciences Inc.'s Enterprise Value?

What is the highest Enterprise Value for Solid Biosciences Inc. (SLDB)?

What is the 3-year average Enterprise Value for Solid Biosciences Inc. (SLDB)?

What is the 5-year average Enterprise Value for Solid Biosciences Inc. (SLDB)?

How does the current Enterprise Value for Solid Biosciences Inc. (SLDB) compare to its historical average?